Bayer AG LAST VERIFIED: August 5, 2026

Bayer AG is a German life-science enterprise founded in 1863, spanning pharmaceuticals, consumer health, and agriculture through its crop science, seeds, and crop protection businesses, under the mission ‘Health for all, Hunger for none.’ It is publicly listed with full investor relations including quarterly and annual reports, maintains a corporate history section dating to its founding, and belongs to the UN Global Compact with published ESG ratings. The company also runs anti-counterfeit programs, including the Bayer Safety Seal and Seal Scan app, reflecting the scale and risk profile of a global pharmaceutical manufacturer.

There are no commercial terms here to evaluate, and that is by design: bayer.com is a corporate site, and products are sold through subsidiaries and channel partners rather than directly. No MOQ, minimum order value, shipping terms, payment methods, or account structures are published. What the site does offer the supply-chain audience is a Supplier Code of Conduct and a formal procurement portal for companies that want to sell to Bayer, plus compliance and transparency documentation. Distributors or pharmacies seeking to buy Bayer products must work through the relevant country subsidiary or licensed pharmaceutical wholesalers.

This domain suits due-diligence researchers, prospective suppliers using the procurement portal, and investors, not product buyers, since no ordering, pricing, or distribution terms are available here, which is the flag to state plainly. The corporate transparency is genuinely strong: ongoing Roundup litigation is openly documented, including a claimed 2026 US Supreme Court win for Monsanto, and counterfeit-protection tools are useful context for anyone handling Bayer-branded goods. Buyers wanting Bayer consumer health or crop products should go to national subsidiaries or established pharma and agri distributors; expecting transactional capability from this site will lead nowhere.